Cronos (CRON) Cash & Equivalents Growth (3y) (2019 - 2026)

Cronos (CRON) Cash & Equivalents Growth (3y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 20.41%
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn -2.73%
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 3.22%
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn -49.65%
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 36.93%
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 10.41%
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn 3.03%
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 1.92%
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn 65.82%
10 Cronos 1.04 Bn 267.78 Mn 19.15 Mn 25.71%

Historic Data

Download Data
DateValue
Mar 31, 2026 25.71%
Dec 31, 2025 1.17%
Sep 30, 2025 7.38%
Jun 30, 2025 0.21%
Mar 31, 2025 -2.53%
Dec 31, 2024 -1.07%
Sep 30, 2024 0.76%
Jun 30, 2024 -1.78%
Mar 31, 2024 -5.84%
Dec 31, 2023 -14.69%
Sep 30, 2023 -19.55%
Jun 30, 2023 -28.28%
Mar 31, 2023 -28.43%
Dec 31, 2022 -13.94%
Dec 31, 2021 229.81%
Dec 31, 2020 429.83%
Dec 31, 2019 673.04%